July 29, 2026 02:12 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Assam floods: Death toll stays at 68 as over 5.24 lakh continue to battle deluge | 'Probe is meaningless if responsibility isn't fixed': Supreme Court slams Delhi Police over CJP protest crackdown | 'No protester will be left alone': CJP claims Centre shared FIR withdrawal copies after midnight talks | Bihar cop suspended after viral AK-47 firing video during NEET protest crackdown | After Dharmendra Pradhan's exit, 'E20 Janta Party' emerges, demands Nitin Gadkari's resignation over fuel policy | 'Can't lathicharge people just because they are protesting': Supreme Court slams Delhi Police over NEET protest crackdown | 'Victory of democracy': Sonam Wangchuk congratulates Gen Z as Dharmendra Pradhan resigns after month-long NEET protests | 'Democracy has triumphed': CJP celebrates as Dharmendra Pradhan quits, warns Centre 'Don't mess with cockroaches' | Centre buckles under CJP-led NEET protests; Dharmendra Pradhan quits as Education Minister | Delhi Police flags 2,500 suspected criminals at Jantar Mantar amid NEET protest
Pixabay

US approved 4 COVID-19 vaccine candidates for clinical trials: FDA Head

| @indiablooms | Jul 01, 2020, at 09:58 am

Washington/Sputnik: The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.

“Four vaccines have been approved for moving into clinical trials... and another six are in the pipeline for us to review,” Hahn said during a press briefing on Tuesday.

The US Administration launched in May Operation Warp Speed, a joint project of Health and Defense Departments, which aims to deliver 300 million doses of a vaccine for COVID-19 by January 2021.

The country’s top pandemics expert Anthony Fauci warned on Tuesday, however, that there is no certainty the United States will be able to develop a vaccine against COVID-19 that works and will be safe.

Data on vaccine effectiveness, he added, may be available in the winter or early next year.  

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.